Consolidated Statement Of Cash Flows

Human Metabolome Technologies, Inc. - Filing #7712025

Concept As at
2019-03-31
2018-04-01 to
2019-03-31
As at
2018-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-356,080,000 JPY
Depreciation
63,683,000 JPY
Interest and dividend income
-235,000 JPY
Interest expenses
593,000 JPY
Foreign exchange losses (gains)
-7,330,000 JPY
Subtotal
-223,364,000 JPY
Decrease (increase) in trade receivables
15,381,000 JPY
Decrease (increase) in inventories
-10,699,000 JPY
Increase (decrease) in trade payables
-12,000 JPY
Net cash provided by (used in) operating activities
-215,344,000 JPY
Other, net
25,852,000 JPY
Interest and dividends received
909,000 JPY
Interest paid
-593,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-137,738,000 JPY
Net cash provided by (used in) investing activities
-47,791,000 JPY
Other, net
-2,439,000 JPY
Cash flows from financing activities
Proceeds from issuance of shares
12,908,000 JPY
Net cash provided by (used in) financing activities
3,455,000 JPY
Repayments of lease liabilities
-9,452,000 JPY
Effect of exchange rate change on cash and cash equivalents
2,544,000 JPY
Net increase (decrease) in cash and cash equivalents
-257,135,000 JPY
Cash and cash equivalents
1,104,243,000 JPY
1,361,379,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.